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 Gamma irradiation has been used by the industries for preservation of herbal 
medicine, but it has not been studied the effect of gamma irradiation on their 
efficacy, especially their bioactivity as anticancer substances. The purpose of this 
research was to study the effect of gamma irradiation on the mahkota dewa leaves 
which has been claimed to contain potent anticancer substances. Maceration of 
dried mahkota dewa leaves successively with n-hexane, ethyl acetate, and ethanol 
gave crude extracts which the ethyl acetate was the most cytotoxic extract against 
leukemia L1210 cells with an inhibition concentration fifty (IC50) value of 
10.3 µg/ml. Further separation of ethyl acetate extract by column chromatograph 
gave 7 fractions, and fraction 2 showed the most cytotoxic fraction exhibited the 
most cytotoxic extract against leukemia L1210 cells with an IC50 value of 
1.9 µg/ml. Since, the fraction 2 of ethyl acetate extract was the most potent 
fraction, the irradiated samples were treated with the same procedure as treatment 
of fraction 2 from control sample. Cytotoxic activity test of fractions 2 from 
irradiated samples showed that the cytotoxic activity decreased depending on 
increasing of irradiation dose. Gamma irradiation dose up to 7.5 kGy on mahkota 
dewa leaves could decreased the cytotoxic activity of fraction 2 as the most 
cytotoxic-potential fraction against leukemia L1210 cells, but decreasing the 
cytotoxic activity has not exceeded the limit of the fraction declared inactive. So 
that the irradiation dose up to 7.5 kGy can be used for decontamination of bacteria 
and fungus/yeast without eliminating the cytotoxic activity. Gamma irradiation also 
caused changes in the thin layer chromatograph (TLC) spots and HPLC 
chromatograms profiles of fraction 2 which was the most cytotoxic fraction in ethyl 
acetate extract of mahkota dewa leaves against leukemia L1210 cells. One of the 
main peaks (peak 1) on HPLC chromatograms decreased with increasing the 
irradiation dose. In agree with the decreasing peak 1 in chromatogram of fraction 2 
due to irradiation, cytotoxic activity of fraction 2 also decreased along with 
increasing doses of irradiation. It suggested that peak 1 is the component that 
contributes to the cytotoxic activity of fraction 2 in ethyl acetate extract of mahkota 
dewa leaves. 
 





Mahkota dewa, Phaleria macrocarpa 
(Scheff.) Boerl (Thymelaeaceae) is one of the 
Indonesian medicinal plants which is recently 
popular due to its ability for treating various 
diseases, namely cancer, tumors, diabetes mellitus, 
hypertension, hepatitis, rheumatism, gout, skin 
diseases, kidney disorders, allergies, asthma, cold, 
haemorrhoid, stroke, and migraine [1,2,3]. Leaves 
and bark of mahkota dewa contained alkaloids, 
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terpenoids, flavonoids, polyphenols, saponins, 
resins, lignin, and benzophenones [1,4,5]. 
The stems of mahkota dewa believed to be 
able to heal bone cancer, meanwhile eggshell of the 
fruits or seeds more efficacious compared with the 
bark and fruit flesh. Seeds of mahkota dewa is only 
used for external treatment especially skin diseases 
[6]. Some several benefits in the plant of mahkota 
dewa has been discovered, moreover the research to 
explore active compounds from mahkota dewa has 
been started. In 2003, it has been reported that one 
of the fraction of methanol extract from the               
leaves of mahkota dewa showed the cytotoxic 
activity against Artemia salina with the LC50         
Atom Indonesia V l. 37  No. 1 (2011) 17 - 23 
 
17
E. Katrin, et al  / Atom Indonesia Vol. 37 No. 1  (2011) 17 - 23 
 
  
(lethal concentration fifty) value of 1.04 µg/ml. 
Furthermore, the same fraction also exhibited 
inhibitory activity against myeloma cells (NS-1) 
with an IC50 value of 81 µg/ml [7]. An IC50 is the 
concentration of the tested samples that can inhibit 
cell proliferation as much as 50%. The                      
same researcher has isolated 4,5-dihydroxy-4'-
methoxybenzophenone-3-O-β-D-glucoside so called 
phalerin from the methanol extract of mahkota dewa 
leaves [8]. Recently this structure has been                         
revised by Oshimi [9] as 2,4,6-trihydroxy-4-
methoxybenzophenone-2-O-β-D-glucoside. 
Chloroform extract of mahkota dewa leaf 
showed an antiproliferation activity against cervical 
cancer cells HeLa (IC50 40.2 µg/ml), melanoma skin 
cancer cells HM3KO (IC50 62.9 µg/ml) and breast 
cancer cell MCF-7 (IC50 70.8 µg/ml) [10]. In the 
other hand, ethyl acetate extract of mahkota dewa 
bark showed the highest cytotoxic activity against 
L1210 leukemia cells compared with n-hexane 
extract and ethanol with an IC50 value of 10.2 µg/ml. 
Further fractionation of this ethyl acetate extract 
gave fraction 2 was the most active fraction with the 
IC50 value of 8.3 µg/ml [11]. The phalerin has also 
been isolated from the mahkota dewa bark [12]. 
In the recent years, the use of herbal 
medicines for complementary treatments of some 
diseases has been popular. While, dry herbs easily 
damaged during storage due to microbial 
contamination, cause reducing the efficacy and 
quality of herbal medicines. To overcome this 
problem, gamma irradiation can be used. Codex 
Alimentarius Commission stating that ionizing 
radiation has been used to decontaminate the 
pathogenic microbes and to extend the shelf life of 
herbs, foods, and spices with the maximum 
absorbed dose should not exceed 10 kGy, except 
when necessary to achieve legitimate technological 
purposes [13]. In Indonesia the regulation of the 
ionizing radiation for sterilization of products has 
been regulated by the Minister of Health No. 
701/MENKES/PER/VIII/2009 [14]. Irradiation dose 
up to 10 kGy can reduce the number of bacteria on 
mahkota dewa dried powder from 1010 cfu/g to              
105 cfu/g [15], this value is qualified according to 
The National Agency of Drug and Food Control 
(NADFC = BPOM) [16]. Gamma irradiation 
technique has several advantages including high 
penetrating energy, is processed at room 
temperature, leaving no residue, environmentally 
friendly, and can be packaged in the end products 
[13,16]. 
In spite of gamma irradiation has been used 
by some of the herbal medicine industries, but the 
effect of gamma irradiation on the efficacies has not 
been studied yet. In previous study, gamma 
irradiation with doses up to 7.5 kGy on the mahkota 
dewa bark could be used for decontamination of 
pathogenic microbes and to extend the self life 
without affecting the cytotoxic activity on L1210 
leukemia cancer cells [15]. In this report, the 
samples which had been irradiated at the dose of    
7.5 kGy were examined the bioactivity in               
vitro against human cancer cell lines,               
namely: cervical cancer cells HeLa, leukemia               
THP-1, lymphoma HUT-78, and lung carcinoma               
A-549. The aim of this study was to               
examine whether the irradiation dose of 7.5 kGy 
does not eliminate there efficacies as anticancer 









Flush column chromatography was carried out 
on silica gel 60 (70 to 230 mesh ASTM, Merck). 
Thin-layer chromatography on silica gel 60 F254 
plate (Merck) was used for monitoring and  
checking the fractions collected from column 
chromatography. The spots on TLC were detected 
by short (254 nm) and long wavelength (366 nm) 
ultraviolet light and visualized by spraying the 
plates with 1% Ce (SO4)2 in 10% aqueous sulfuric 
acid followed by heating. Concentrating of extracts 
and fractions were done by using a rotary evaporator 
in vacuo in temperature of 35οC followed by drying 
in oven desiccator in vacuo at 40οC until fix weight 
of the fractions were obtained. Analysis components 
of fractions by HPLC was done on a Shimadzu            
LC-6A equipped with UV-detector at 210 nm, C-18 
reverse phase coloumn of varian microsorb MV 
100-5 with dimension of 250 mm length and               
4.6 mm inner diameter, and the comparison of 
mobile phase methanol to water was 7:3.  
 
 
Materials and apparatus 
 
The leaves of mahkota dewa Phaleria 
macrocarpa (Scheff.) Boerl were collected from 
Cibeuteung village, Parung, West Java, Indonesia in 
May 2006 as described in previous report, and 
determined by Herbarium Bogoriensis, Research 
Center for Biology, Indonesian Institute of Sciences, 
Bogor, Indonesia [11]. The leaves of mahkota dewa 
were then dried, sliced and blended. 
The leukemia L210 cells used for cytotoxicity 
test was liquid cancer cells line isolated from DBA 
strain mouse induced by methylcholanthrene. 
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Chemicals used in this study were n-hexane, 
ethyl acetate, ethanol, tryphan blue 0.4 %, RPMI 
Medium-1640, fetal bovine serum (FBS),                  
liquid nitrogen, distilled water, aquabidest, 
chloroform, methanol, cerium sulfate, H2SO4,           
silica gel 60 (70-230 mesh), celite 545, GF254            
silica plate. 
Apparatus used were Gamma Irradiator               
from cobalt-60 with an activity of 140 kCi,                    
high performance liquid chromatograph             
(Shimadzu LC 6-A), column chromatograph 
(diameter 8 cm and length 90 cm), vacuum rotary 
evaporator (Büchi), oven (Prolabo), multi-well plate 
tissue's culture, haemocytometer Neubauer (0.100 
mm × 0.0025 mm2), hot plate, ultrasonicator, oven 
desiccator, analytical balance (Mettler Toledo), 
autoclave (S4-ON), incubator, microscope. 
 
 
Preparation and irradiation of samples  
The dried mahkota dewa leaves                          
was powdered, then was weighed each 100 g                   
and put in polyethylene bags and sealed                        
with a sealer machine. Ten samples were               
preferred. The each two samples were irradiated                
at a dose of 0 (control), 5, 7.5, 10, and 15 kGy              
with  dose rate of 10 kGy/h. Determination                   
of the dose was done by Fricke solution as a       
primary standard dosimeter consisting of                    
0.001 M of ferrous ammonium sulfate                             
and 0.001 M of sulfuric acid.  
 
 
Preparation and separation of extracts by 
column chromatograph 
The control and irradiated samples                    
were macerated as much as four times, each                 
time with 1.4 L of n-hexane. The residue was              
again extracted with ethyl acetate and                            
then with ethanol with the same procedure as 
maceration with n-hexane. The each                        
filtrate  obtained was concentrated using a rotary 
evaporator followed by drying in oven desiccators 
in vacuo. 
The most active extract against leukemia 
L1210 cell line was fractionated using silica                 
gel column chromatograph. Amount of 1.0 g of 
extract was homogenized with celite, then subjected 
into column chromatograph and was                 
gradiently eluted by n-hexane - ethyl acetate - 
methanol (1:0:0, 5:1:0, 3:1:0, 0:1:0, 0:1:1, 0:0:1). 
Each fraction was collected with a volume                
of 150 ml. The fraction obtained was concentrated 
using a rotary evaporator followed by                      
drying in oven desiccator in vacuo. The obtained 
fractions were analyzed by TLC and the fractions 
that had a similar spot pattern were merged. 
 
Analysis of fractions by HPLC  
The most active fractions from control and 
irradiated samples which have been examined 
against leukemia L1210 were then analyzed by high 
performance liquid chromatograph (HPLC). 
Amount of 1.6 mg fraction was dissolved in 1 ml 
methanol, filtered with membrane filter (0.45 µm), 
then 20 µl of solution was injected into the HPLC.  
 
 
Cytotoxic activity test against mouse 
leukemia L1210 cell line [12] 
Exponentially growing leukemia L1210 cells 
at a density of 2 × 105 cells/ml suspended in RPMI-
1640 medium was placed into serocluster 24 wells 
plate, the sample solution of extracts or fractions in 
various concentrations were added then incubated at 
37οC for 48 h under 5% CO2 condition. The varying 
concentration of extracts were 0 (control),  5, 10, 20, 
40, and 80 µg/ml, meanwhile the varying 
concentration of fractions were 0(control), 1, 2, 4, 8, 
and 16 µg/ml. Control consisted of exposed to fresh 
medium only. Duplicate wells were prepared for 
each concentration of extracts or fractions and 
control. Ninety µl of cell suspension in every well 
was pipetted and put into serocluster plate and 10 µl 
of tryphan blue was added and the mixture was 
homogenized. Furthermore, 10 µl of suspension was 
put in haemocytometer and the amount of viable 
cells of the samples and control were enumerated by 
microscope. The inhibition percentage was 
calculated as the following equation. 
 
% inhibition =
[ cells in control] - [ cells in sample]
[ cells in control]
x 100 %
 
By making the graph of sample concentration in 
logarithm (X axes) versus probit of % inhibition               
(Y axes), the linear regression equation Y = aX + b is 
obtained. The inhibition concentration-fifty (IC50) 
which expresses the ability of the samples to inhibit 
50% of cancer cell proliferation is calculated by the 
substitution of Y by 5 (probit value of 50) to the 
linear regression equation Y = aX + b. Subsequently, 
IC50 value = antilogarithm of X = {antilogarithm of 
(5-b)/a} can be determined. 
 
 
Data analysis  
The data of analysis IC50 values and               
HPLC chromatogram for studying the effect of 
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gamma irradiation toward cytotoxic activity               
of the samples, was performed by one-way ANOVA    
using SPSS 17.0 for windows in the                     
confidence level of 95%.  
 
 
RESULTS AND DISCUSSION 
 
Maceration from 100 g of control               
and irradiated samples by n-hexane, ethyl               
acetate, and ethanol was shown in Table 1.               
It can be seen that the yield of n-hexane                
extracts from control and irradiated samples                  
did not significantly change, but the                           
yield of ethyl acetate extracts as                                   
well as ethanol extracts from irradiated                    
samples at doses of 10 and 15 kGy,                       
slightly increased. This is apparently due                            
to radiation energy causing the samples                  
become soft and brittle, making the chemical 
components was more easily extracted.  
 
 
Table 1. The yield of extracts from control and irradiated 
mahkota dewa leaves. 
 
 
Furthermore, the extracts from                          
control sample (non irradiated sample)                          
then were assayed their cytotoxic                             
activity against leukemia L1210 cells line.                    
The obtained inhibition percentage value                      
was converted to probit value and then                       
was performed in linear curve versus log                        
of ethyl acetate extract concentration as                           
seen in Fig. 1. Inhibition concentration fifty                     
(IC50) value was calculated based on                               
the linear equation Y = 5, then it was                     
obtained the concentration as IC50.                               
The results showed that all extracts                     
exhibited  cytotoxic activity with an IC50 < 30 µg/ml 
(Table 2).  
 
Fig. 1. Curve of log of samples concentrations versus probit of 
inhibition percentage. 
 
Table 2. Inhibition percentage of ethanol, n-hexane, and ethyl 
acetate extracts from control sample against leukemia L1210 










linearity value, R 
ethanol 
extract 
5 28.2  
24.1 
 
Y = 1.771 X + 3.238







5 27.4  
12.4 
 
Y = 1.678 X + 3.175








5 8.2  
10.3 
 
Y = 2.432 X + 1.764





According to the American National Cancer 
Institute quoted by Nor Aini et al. [17] and 
Magalhaes et al. [18], an extract exhibits a potent 
anticancer if the IC50 value < 30 µg/ml, while 
according to Mans et al. [19], an extract exhibits a 
potent anticancer if the IC50 value < 50 µg/ml. 
Among the extracts, the ethyl acetate extract gave 
highest cytotoxicity against leukemia L1210 cells 
(IC50 10.3 µg/ml) compared to n-hexane extract 
(12.4 µg/ml) and ethanol extract (IC50 24.1 µg/ml), 
so in this experiment, ethyl acetate extract has been 
chosen to be further separation using column 
Dose 
(kGy) 











0 2.3 5.9 18.8 
5 2.4 5.9 19.2 
7.5 2.4 5.3 19.2 
10 2.3 7.1 19.5 
15 2.4 7.1 19.7 
20 
1.  ethanol extract
  Y = 1.771 X + 3.238 
        R = 0979 
2. n-hexane extract
Y = 1.678 X + 3.175
        R = 0995 
3. ethyl acetate extract
Y = 2.432 X + 1.764 
        R = 0983 
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chromatograph. Subsequently, to study the                
effect of irradiation onto the leaves of                     
mahkota dewa, the ethyl acetate extract                      
from irradiated sample were then assayed               
and also further separation using column 
chromatograph as the same manner as                
treatment of the control sample. 
Fractionation of ethyl acetate extract                   
from control sample gave 7 fractions                   
(Fr.1-Fr.7). Furthermore the Fr.1-Fr.7 were                   
then assayed against leukemia L1210 cells                     
as the same manner as bioassay of extracts,                   
gave IC50 values as presented in Table 3.                    
Since, Fr.2 was showed the lowest IC50                           
value (1.9 µg/ml) (Table 3), it indicated                         
the Fr.2 was the most active fraction                                   
which exhibited cytotoxic activity against               
leukemia L1210 cells, so assayed the                    
fractions from irradiated samples was done                 
toward only Fr.2.  
 
Table 3. The yield and IC50 value Fr.1-Fr.7 of ethyl acetate 







Fr.1 6 0.6 4.2 
Fr.2 21 2.1 1.9 
Fr.3 18 1.8 4.3 
Fr.4 174 17.4 4.4 
Fr.5 72 7.2 5.6 
Fr.6 676 67.6 5.0 
Fr.7 30 3.0 5.0 
 
Table 4 showed the comparison of IC50  
values of ethyl acetate extracts and Fr.2                      
from control and irradiated samples.                        
Based on the IC50 values of ethyl acetate                   
extract and Fr.2, it appeared that gamma                   
irradiation tends to cause the IC50 value                   
increased, which means the cytotoxic                       
activity decreased, but the increasing of                       
IC50 value at irradiation dose until 15 kGy                     
has not exceeded the limit of an                              
extract and the fraction was declared inactive                
[17]. Nevertheless, irradiation at the dose of                     
7.5 kGy caused the IC50 values of Fr.2                  
significantly increased. So it is recommended                    
that the irradiation of mahkota dewa               
leaves for decontamination of bacteria               
and fungus/yeast and for preserving               
and extending its self life without eliminating               
the cytotoxic activity was no more than               
7.5 kGy. 
  
Table 4. IC50 comparison of ethyl acetate extract and Fr.2            
from control and from irradiated samples. 
 
Sample 












10.3 a 14.7 b,c 14.2 b,c 13.2 a,b 17.1 c 
Fr.2 1.9 a 2.4 ab 3.1 b 4.0 c 5.8 d 
Note: Similar letters as superscript indicate that they were not 
significantly difference. 
 
Furthermore, to study the effect of               
gamma irradiation on the components               
presence in the Fr.2, the TLC spot and               
HPLC chromatogram profiles of Fr.2 from               
control and irradiated samples were               
compared. Figure 2 shows the TLC spots             
profile of Fr.2 from control and irradiated              
samples. It appeared that at least 8 spots               
included in the Fr.2 from control sample               
(0 kGy). Irradiation dose of 7.5, 10, and               
15 kGy caused spot 3 significantly decreased, 
meanwhile spots 7 and 8 seem to be increased               
at irradiation dose of 15 kGy. The decreasing               
of spot 3 means those compounds               
degraded to another compounds, probably               
become compound included in the spots 7 and 8. It 
suggested that the spot 3 contained the               
active substances which have cytotoxic               




Fig. 2. TLC spots profile of Fr.2 from control and irradiated 
samples. 
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Fig. 4. The effect of  irradiation dose of peak 1 and peak 2 of  
HPLC chromatogram profile of Fr.2. 
 
Further analysis of Fr.2 by HPLC equipped 
with UV detector at 210 nm showed that there                
was major peak at retention time of 8.8 min               
(peak 1) and other minor peaks, such as peak 2 at 
retention time of 23.6 min (Fig. 3). Peak 1 
significantly decreased with increasing the 
irradiation dose by follows the quadratic equation  
(Y = - 0.26 X2 + 0.03 X + 101), meanwhile peak 2 
was increased with increasing the irradiation dose 
by follows the quadratic equation  (Y = 0.19 X2 + 
7.52 X + 3.98). The changed of peaks 1 and 2 was 
shown in Fig. 4.  
Reducing peak 1 in HPLC chromatogram of 
Fr.2 as well as spot 3 in TLC spot profile is likely 
correlated with reducing cytotoxic activity of Fr.2 
due to the increasing radiation dose. It also 
suggested that the peak 1 was the active substance 






Gamma irradiation causes changes in the TLC 
spots and HPLC chromatograms profiles of fraction 
2 (Fr.2) which was the most cytotoxic fraction in 
ethyl acetate extract of mahkota dewa leaves  
against leukemia L1210 cells. One of the main peak 
(peak 1) on HPLC chromatograms decreased, 
whereas the other peak (peak 2) which was a small 
peak in HPLC chromatogram of fraction 2 from non 
irradiated sample increased with increasing the 
irradiation dose. In agree with the decreasing peak    
1 in chromatogram of fraction 2 due to irradiation, 
cytotoxic activity  of fraction 2 also decreased along 
with increasing doses of irradiation. It suggested 
that peak 1 is  the component that contributes to the 
cytotoxic activity of fraction 2 in ethyl acetate 
extract of mahkota dewa leaves. 
Gamma irradiation dose of 7.5 kGy on 
mahkota dewa leaves could decreased the cytotoxic 
activity of fraction 2 as the most cytotoxic-potential 
fraction against leukemia L1210 cells, but 
decreasing the cytotoxic activity has not exceeded 
the limit of the fraction declared inactive. So that the 
irradiation dose up to 7.5 kGy can be use for 
decontamination of bacteria and fungus/yeast 
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